Cognitive Profile and Markers of Alzheimer Disease–Type Pathology in Patients With Lewy Body Dementias

Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies

(2020) Denis S. Smirnov et al.   NEUROLOGY

Amyloid-β and tau biomarkers and clinical phenotype in dementia with Lewy bodies

(2020) Daniel Ferreira et al.   NEUROLOGY

Multimodal in vivo and postmortem assessments of tau in Lewy body disorders

(2020) David G. Coughlin et al.   NEUROBIOLOGY OF AGING

Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report

(2019) Peter T Nelson et al.   BRAIN

CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies

(2019) Rita Di Censo et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases

(2019) David G. Coughlin et al.   MOVEMENT DISORDERS

The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies

(2018) Tanis J. Ferman et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated

(2018) John L Robinson et al.   BRAIN

Episodic memory decline in Parkinson’ s disease: relation with white matter hyperintense lesions and influence of quantification method

(2018) Vincent Dunet et al.   Brain Imaging and Behavior

Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders

(2018) David G. Coughlin et al.   ANNALS OF NEUROLOGY

Alzheimer’s Disease Biomarkers and Future Decline in Cognitive Normal Older Adults

(2017) Julien Dumurgier et al.   JOURNAL OF ALZHEIMERS DISEASE

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

(2017) David J Irwin et al.   LANCET NEUROLOGY

Spotlight on the January 2 issue

(2017) Robert A. Gross   NEUROLOGY

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Narrative Organization Deficit in Lewy Body Disorders Is Related to Alzheimer Pathology

(2017) Murray Grossman et al.   Frontiers in Neuroscience

Results From the NACC Uniform Data Set Neuropsychological Battery Crosswalk Study

(2016) Sarah E. Monsell et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Survival and dementia inGBA-associated Parkinson's disease: The mutation matters

(2016) Roberto Cilia et al.   ANNALS OF NEUROLOGY

AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies

(2016) Kejal Kantarci et al.   ANNALS OF NEUROLOGY

Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies

(2016) A W Lemstra et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Arguing against the proposed definition changes of PD

(2016) Bradley F. Boeve et al.   MOVEMENT DISORDERS

Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies

(2016) Guerry M. Peavy et al.   PARKINSONISM & RELATED DISORDERS

Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases

(2016) Stephen N. Gomperts et al.   JAMA Neurology

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies

(2015) Zuzana Nedelska et al.   NEUROBIOLOGY OF AGING

The spectrum of cognitive impairment in Lewy body diseases

(2014) Jennifer G. Goldman et al.   MOVEMENT DISORDERS

Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI

(2013) Jon B. Toledo et al.   ACTA NEUROPATHOLOGICA

A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank

(2013) Jon B. Toledo et al.   Alzheimers & Dementia

Changes in Brain Function Occur Years before the Onset of Cognitive Impairment

(2013) L. L. Beason-Held et al.   JOURNAL OF NEUROSCIENCE

Neuropsychologic assessment in collaborative Parkinson’s disease research: A proposal from the National Institute of Neurological Disorders and Stroke Morris K. Udall Centers of Excellence for Parkinson’s Disease Research at the University of Pennsylvania and the University of Washington

(2012) G. Stennis Watson et al.   Alzheimers & Dementia

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

(2011) Mariely DeJesus-Hernandez et al.   NEURON

Cognitive and Neuropsychiatric Profile of the Synucleinopathies

(2010) Aimee W. Kao et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Bilateral brain regions associated with naming in older adults

(2010) Loraine K. Obler et al.   BRAIN AND LANGUAGE

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson’s disease

(2010) James B. Leverenz et al.   PARKINSONISM & RELATED DISORDERS

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

(2008) Kurt A. Jellinger et al.   ACTA NEUROPATHOLOGICA

Imaging amyloid deposition in Lewy body diseases

(2008) S. N. Gomperts et al.   NEUROLOGY

Neuropsychological Characteristics of Dementia with Lewy Bodies and Parkinson’s Disease with Dementia: Differentiation, Early Detection, and Implications for “Mild Cognitive Impairment” and Biomarkers

(2008) Alexander I. Tröster   NEUROPSYCHOLOGY REVIEW